Vitestro is a global leader in medical robotics focused on advancing diagnostic blood collection through autonomous technology. The company has developed the Aletta® Autonomous Robotic Phlebotomy Device™ (ARPD™), the world's first and only CE-marked device in its category. By integrating advanced robotics, multimodal imaging, and AI, Vitestro aims to improve precision, operational efficiency, and the patient experience in clinical settings. The company is actively pursuing U.S. FDA authorization and expanding global clinical collaborations.